CONSOLIDATED STATEMENT OF OPERATIONS - USD ($) shares in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017
Net sales (Note 3)	$ (1,910,000,000)	$ (1,872,000,000)	$ (5,840,000,000)	$ (5,373,000,000)
Costs of products sold	1,452,000,000	1,374,000,000	4,247,000,000	3,982,000,000
Gross margin	458,000,000	498,000,000	1,593,000,000	1,391,000,000
Selling expenses	20,000,000	22,000,000	66,000,000	66,000,000
General and administrative expenses	78,000,000	75,000,000	236,000,000	238,000,000
Research and development expenses	2,000,000	4,000,000	6,000,000	12,000,000
Charges for integration and restructuring, closures and asset impairments (Note 15)	0	14,000,000	2,000,000	178,000,000
Charges (recoveries) for product remediation, net (Note 16)	0	190,000,000	0	240,000,000
Other operating costs (income), net (Note 17)	21,000,000	(12,000,000)	66,000,000	2,000,000
Operating income	337,000,000	205,000,000	1,217,000,000	655,000,000
Non-operating pension and other postretirement benefit costs	(17,000,000)	(16,000,000)	(54,000,000)	(46,000,000)
Interest income and other	13,000,000	12,000,000	36,000,000	30,000,000
Interest expense, net of capitalized interest	(93,000,000)	(98,000,000)	(278,000,000)	(297,000,000)
Earnings before income taxes	240,000,000	103,000,000	921,000,000	342,000,000
Income taxes (Note 18)	15,000,000	27,000,000	(80,000,000)	(31,000,000)
Net earnings	$ 255,000,000	$ 130,000,000	$ 841,000,000	$ 311,000,000
Earnings per share, basic and diluted (Note 5)	$ 0.34	$ 0.17	$ 1.11	$ 0.41
Dividends paid per share	$ 0.34	$ 0.31	$ 0.98	$ 0.93
Weighted average shares outstanding (in thousands) (Note 5):
Basic	754,986	753,535	756,531	752,301
Diluted	757,389	756,903	759,116	756,058